{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T13:18:53Z","timestamp":1783948733116,"version":"3.55.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T00:00:00Z","timestamp":1779235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T00:00:00Z","timestamp":1783900800000},"content-version":"vor","delay-in-days":54,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001843","name":"DST | Science and Engineering Research Board","doi-asserted-by":"publisher","award":["CRG\/2020\/000125"],"award-info":[{"award-number":["CRG\/2020\/000125"]}],"id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001852","name":"Indo-French Centre for the Promotion of Advanced Research","doi-asserted-by":"publisher","award":["IFC\/6803-1\/2022"],"award-info":[{"award-number":["IFC\/6803-1\/2022"]}],"id":[{"id":"10.13039\/501100001852","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001412","name":"Council of Scientific and Industrial Research","doi-asserted-by":"publisher","award":["27\/0387\/23\/EMR-II"],"award-info":[{"award-number":["27\/0387\/23\/EMR-II"]}],"id":[{"id":"10.13039\/501100001412","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology, Ministry of Science and Technology","doi-asserted-by":"publisher","award":["BT\/PR53002\/MED\/30\/2541\/2024"],"award-info":[{"award-number":["BT\/PR53002\/MED\/30\/2541\/2024"]}],"id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Loss of BLM helicase leads to Bloom Syndrome, characterized by genomic instability, cancer predisposition and immunodeficiency. We now show that BLM is essential for the proliferation of cycling B cells and sustains B-cell development by maintaining NF-\u03baB signalling. Hence, in the absence of BLM, the NF-\u03baB pathway is impaired as visualized by the lack of the nuclear translocation of RelA. This action of BLM is due to its binding to the MALT1 promoter (a key positive regulator of NF-\u03baB signalling) and activating its transcription. Reintroduction of MALT1 and constitutively active IKK\u03b2 rescues B-cell development in BLM-deficient bone marrow and spleen cells of BLM knockout mice. This indicates that downregulation of MALT1 in BLM-deficient cells is the primary cause of deregulated NF-\u03baB signalling and impaired B-cell development. Interestingly, the pro-proliferative role of BLM can be exploited in the treatment of B-cell malignancies. Here, we demonstrate that depletion of BLM (phenocopied by the inhibition of MALT1) suppresses the progression of lymphoma and leukaemia by inhibiting MALT1-dependent NF-\u03baB signalling and sensitizing malignant B cells to chemotherapy. Together, our findings establish the BLM-MALT1-NF-\u03baB axis as a critical regulator of B-cell development and demonstrate its therapeutic potential in B-cell malignancies. Hence, both upregulation and downregulation of BLM contribute to oncogenesis, underscoring the need to maintain its expression within a tightly controlled threshold.<\/jats:p>","DOI":"10.1038\/s41419-026-08846-3","type":"journal-article","created":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T22:45:11Z","timestamp":1779230711000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["BLM regulates MALT1-driven NF-\u03baB signalling and is targetable in B-cell malignancies"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-8622-8249","authenticated-orcid":false,"given":"Ritu","family":"Agrawal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Supratim","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nitin","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chetana","family":"Mukherjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vandana","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rimpy","family":"Arun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riya","family":"Deb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumanta","family":"Sarkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Savita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1848-3034","authenticated-orcid":false,"given":"Dilip","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7343-1173","authenticated-orcid":false,"given":"Satyajit","family":"Rath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0249-8856","authenticated-orcid":false,"given":"Arindam","family":"Maitra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6365-1770","authenticated-orcid":false,"given":"Sagar","family":"Sengupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,20]]},"reference":[{"key":"8846_CR1","doi-asserted-by":"publisher","first-page":"458","DOI":"10.12688\/f1000research.13247.1","volume":"7","author":"L Nicolas","year":"2018","unstructured":"Nicolas L, Cols M, Choi JE, Chaudhuri J, Vuong B. Generating and repairing genetically programmed DNA breaks during immunoglobulin class switch recombination. F1000Res. 2018;7:458.","journal-title":"F1000Res"},{"key":"8846_CR2","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/bs.ai.2015.07.006","volume":"128","author":"A Ebert","year":"2015","unstructured":"Ebert A, Hill L, Busslinger M. Spatial regulation of V-(D)J recombination at antigen receptor loci. Adv Immunol. 2015;128:93\u2013121.","journal-title":"Adv Immunol"},{"key":"8846_CR3","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1111\/imr.12670","volume":"284","author":"K Imkeller","year":"2018","unstructured":"Imkeller K, Wardemann H. Assessing human B cell repertoire diversity and convergence. Immunol Rev. 2018;284:51\u201366.","journal-title":"Immunol Rev"},{"key":"8846_CR4","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2021.634789","volume":"12","author":"E Kaur","year":"2021","unstructured":"Kaur E, Agrawal R, Sengupta S. Functions of BLM helicase in cells: Is it acting like a double-edged sword? Front Genet. 2021;12:634789.","journal-title":"Front Genet"},{"key":"8846_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-03393-8","volume":"9","author":"V Tripathi","year":"2018","unstructured":"Tripathi V, Agarwal H, Priya S, Batra H, Modi P, Pandey M, et al. MRN complex-dependent recruitment of ubiquitylated BLM helicase to DSBs negatively regulates DNA repair pathways. Nat Commun. 2018;9:1016.","journal-title":"Nat Commun"},{"key":"8846_CR6","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1083\/jcb.200610051","volume":"178","author":"V Tripathi","year":"2007","unstructured":"Tripathi V, Nagarjuna T, Sengupta S. BLM helicase-dependent and -independent roles of 53BP1 during replication stress-mediated homologous recombination. J Cell Biol. 2007;178:9\u201314.","journal-title":"J Cell Biol"},{"key":"8846_CR7","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1093\/carcin\/bgm238","volume":"29","author":"V Tripathi","year":"2008","unstructured":"Tripathi V, Kaur S, Sengupta S. Phosphorylation-dependent interactions of BLM and 53BP1 are required for their anti-recombinogenic roles during homologous recombination. Carcinogenesis. 2008;29:52\u201361.","journal-title":"Carcinogenesis"},{"key":"8846_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.983181","volume":"13","author":"S Ovejero","year":"2022","unstructured":"Ovejero S, Viziteu E, Dutrieux L, Devin J, Lin YL, Alaterre E, et al. The BLM helicase is a new therapeutic target in multiple myeloma involved in replication stress survival and drug resistance. Front Immunol. 2022;13:983181.","journal-title":"Front Immunol"},{"key":"8846_CR9","doi-asserted-by":"publisher","first-page":"JCI161941.","DOI":"10.1172\/JCI161941","volume":"134","author":"E Kaur","year":"2024","unstructured":"Kaur E, Agrawal R, Arun R, Madhavan V, Srivastava V, Kumar D, et al. Small molecules that disrupt RAD54-BLM interaction hamper tumor proliferation in colon cancer chemoresistance models. J Clin Investig. 2024;134:JCI161941.","journal-title":"J Clin Investig"},{"key":"8846_CR10","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1038\/s41392-025-02302-y","volume":"10","author":"X Li","year":"2025","unstructured":"Li X, Zhang C, Mei Y, Zhong W, Fan W, Liu L, et al. Irinotecan alleviates chemoresistance to anthracyclines through the inhibition of AARS1-mediated BLM lactylation and homologous recombination repair. Signal Transduct Target Ther. 2025;10:214.","journal-title":"Signal Transduct Target Ther"},{"key":"8846_CR11","doi-asserted-by":"publisher","first-page":"3551","DOI":"10.1245\/s10434-022-11500-9","volume":"29","author":"C Lan","year":"2022","unstructured":"Lan C, Yamashita YI, Hayashi H, Nakagawa S, Imai K, Mima K, et al. High expression of bloom syndrome helicase is a key factor for poor prognosis and advanced malignancy in patients with pancreatic cancer: a retrospective study. Ann Surg Oncol. 2022;29:3551\u201364.","journal-title":"Ann Surg Oncol"},{"key":"8846_CR12","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1128\/MCB.01402-06","volume":"27","author":"H Babbe","year":"2007","unstructured":"Babbe H, Chester N, Leder P, Reizis B. The Bloom\u2019s syndrome helicase is critical for development and function of the alphabeta T-cell lineage. Mol Cell Biol. 2007;27:1947\u201359.","journal-title":"Mol Cell Biol"},{"key":"8846_CR13","doi-asserted-by":"publisher","first-page":"347","DOI":"10.4049\/jimmunol.182.1.347","volume":"182","author":"H Babbe","year":"2009","unstructured":"Babbe H, McMenamin J, Hobeika E, Wang J, Rodig SJ, Reth M, et al. Genomic instability resulting from Blm deficiency compromises development, maintenance, and function of the B cell lineage. J Immunol. 2009;182:347\u201360.","journal-title":"J Immunol"},{"key":"8846_CR14","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s10875-017-0454-y","volume":"38","author":"MHD Schoenaker","year":"2018","unstructured":"Schoenaker MHD, Henriet SS, Zonderland J, van Deuren M, Pan-Hammarstrom Q, Posthumus-van Sluijs SJ, et al. Immunodeficiency in Bloom\u2019s Syndrome. J Clin Immunol. 2018;38:35\u201344.","journal-title":"J Clin Immunol"},{"key":"8846_CR15","first-page":"111","volume":"66","author":"A Diaz","year":"2006","unstructured":"Diaz A, Vogiatzi MG, Sanz MM, German J. Evaluation of short stature, carbohydrate metabolism and other endocrinopathies in Bloom\u2019s syndrome. Horm Res. 2006;66:111\u20137.","journal-title":"Horm Res"},{"key":"8846_CR16","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1111\/j.1651-2227.1992.tb12088.x","volume":"81","author":"N Kondo","year":"1992","unstructured":"Kondo N, Motoyoshi F, Mori S, Kuwabara N, Orii T, German J. Long-term study of the immunodeficiency of Bloom\u2019s syndrome. Acta Paediatr. 1992;81:86\u201390.","journal-title":"Acta Paediatr"},{"key":"8846_CR17","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1001\/archpedi.1988.02150100083032","volume":"142","author":"CW Van Kerckhove","year":"1988","unstructured":"Van Kerckhove CW, Ceuppens JL, Vanderschueren-Lodeweyckx M, Eggermont E, Vertessen S, Stevens EA. Bloom\u2019s syndrome. Clinical features and immunologic abnormalities of four patients. Am J Dis Child. 1988;142:1089\u201393.","journal-title":"Am J Dis Child"},{"key":"8846_CR18","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/B978-0-12-394300-2.00006-5","volume":"116","author":"JJ Bednarski","year":"2012","unstructured":"Bednarski JJ, Sleckman BP. Lymphocyte development: integration of DNA damage response signaling. Adv Immunol. 2012;116:175\u2013204.","journal-title":"Adv Immunol"},{"key":"8846_CR19","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.ceb.2017.10.002","volume":"51","author":"E Schweighoffer","year":"2018","unstructured":"Schweighoffer E, Tybulewicz VL. Signalling for B cell survival. Curr Opin Cell Biol. 2018;51:8\u201314.","journal-title":"Curr Opin Cell Biol"},{"key":"8846_CR20","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1214095","volume":"14","author":"C Guldenpfennig","year":"2023","unstructured":"Guldenpfennig C, Teixeiro E, Daniels M. NF-kB\u2019s contribution to B cell fate decisions. Front Immunol. 2023;14:1214095.","journal-title":"Front Immunol"},{"key":"8846_CR21","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/nri1629","volume":"5","author":"U Siebenlist","year":"2005","unstructured":"Siebenlist U, Brown K, Claudio E. Control of lymphocyte development by nuclear factor-kappaB. Nat Rev Immunol. 2005;5:435\u201345.","journal-title":"Nat Rev Immunol"},{"key":"8846_CR22","doi-asserted-by":"publisher","first-page":"14596","DOI":"10.1073\/pnas.1105020108","volume":"108","author":"S Hailfinger","year":"2011","unstructured":"Hailfinger S, Nogai H, Pelzer C, Jaworski M, Cabalzar K, Charton JE, et al. Malt1-dependent RelB cleavage promotes canonical NF-kappaB activation in lymphocytes and lymphoma cell lines. Proc Natl Acad Sci USA. 2011;108:14596\u2013601.","journal-title":"Proc Natl Acad Sci USA"},{"key":"8846_CR23","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1073\/pnas.1721967115","volume":"115","author":"L David","year":"2018","unstructured":"David L, Li Y, Ma J, Garner E, Zhang X, Wu H. Assembly mechanism of the CARMA1-BCL10-MALT1-TRAF6 signalosome. Proc Natl Acad Sci USA. 2018;115:1499\u2013504.","journal-title":"Proc Natl Acad Sci USA"},{"key":"8846_CR24","doi-asserted-by":"publisher","first-page":"gkaf106.","DOI":"10.1093\/nar\/gkaf106","volume":"53","author":"R Agrawal","year":"2025","unstructured":"Agrawal R, Agarwal H, Mukherjee C, Chakraborty B, Sharma V, Tripathi V, et al. Phosphorylated BLM peptide acts as an agonist for DNA damage response. Nucleic Acids Res. 2025;53:gkaf106.","journal-title":"Nucleic Acids Res"},{"key":"8846_CR25","doi-asserted-by":"publisher","first-page":"2279","DOI":"10.1038\/s44318-025-00402-7","volume":"44","author":"R Agrawal","year":"2025","unstructured":"Agrawal R, Sengupta S. p53 regulates DREAM complex-mediated repression in a p21-independent manner. EMBO J. 2025;44:2279\u201397.","journal-title":"EMBO J"},{"key":"8846_CR26","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","volume":"25","author":"H Li","year":"2009","unstructured":"Li H, Durbin R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics. 2009;25:1754\u201360.","journal-title":"Bioinformatics"},{"key":"8846_CR27","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/nmeth.1802","volume":"9","author":"BK Koo","year":"2011","unstructured":"Koo BK, Stange DE, Sato T, Karthaus W, Farin HF, Huch M, et al. Controlled gene expression in primary Lgr5 organoid cultures. Nat Methods. 2011;9:81\u20133.","journal-title":"Nat Methods"},{"key":"8846_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms14049","volume":"8","author":"GX Zheng","year":"2017","unstructured":"Zheng GX, Terry JM, Belgrader P, Ryvkin P, Bent ZW, Wilson R, et al. Massively parallel digital transcriptional profiling of single cells. Nat Commun. 2017;8:14049.","journal-title":"Nat Commun"},{"key":"8846_CR29","doi-asserted-by":"publisher","first-page":"3573","DOI":"10.1016\/j.cell.2021.04.048","volume":"184","author":"Y Hao","year":"2021","unstructured":"Hao Y, Hao S, Andersen-Nissen E, Mauck WM 3rd, Zheng S, et al. Integrated analysis of multimodal single-cell data. Cell. 2021;184:3573\u201387.e29.","journal-title":"Cell"},{"key":"8846_CR30","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.cels.2019.03.003","volume":"8","author":"CS McGinnis","year":"2019","unstructured":"McGinnis CS, Murrow LM, Gartner ZJ. Doubletfinder: doublet detection in single-cell RNA sequencing data using artificial nearest neighbors. Cell Syst. 2019;8:329\u201337.e4.","journal-title":"Cell Syst"},{"key":"8846_CR31","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1038\/s41592-019-0619-0","volume":"16","author":"I Korsunsky","year":"2019","unstructured":"Korsunsky I, Millard N, Fan J, Slowikowski K, Zhang F, Wei K, et al. Fast, sensitive and accurate integration of single-cell data with Harmony. Nat Methods. 2019;16:1289\u201396.","journal-title":"Nat Methods"},{"key":"8846_CR32","doi-asserted-by":"publisher","first-page":"W90","DOI":"10.1093\/nar\/gkw377","volume":"44","author":"MV Kuleshov","year":"2016","unstructured":"Kuleshov MV, Jones MR, Rouillard AD, Fernandez NF, Duan Q, Wang Z, et al. Enrichr: a comprehensive gene set enrichment analysis web server 2016 update. Nucleic Acids Res. 2016;44:W90\u20137.","journal-title":"Nucleic Acids Res"},{"key":"8846_CR33","first-page":"100141","volume":"2","author":"T Wu","year":"2021","unstructured":"Wu T, Hu E, Xu S, Chen M, Guo P, Dai Z, et al. clusterProfiler 4.0: a universal enrichment tool for interpreting omics data. Innov (Camb). 2021;2:100141.","journal-title":"Innov (Camb)"},{"key":"8846_CR34","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/s41587-021-01033-z","volume":"40","author":"E Dann","year":"2022","unstructured":"Dann E, Henderson NC, Teichmann SA, Morgan MD, Marioni JC. Differential abundance testing on single-cell data using k-nearest neighbor graphs. Nat Biotechnol. 2022;40:245\u201353.","journal-title":"Nat Biotechnol"},{"key":"8846_CR35","doi-asserted-by":"publisher","first-page":"7088","DOI":"10.1128\/MCB.19.10.7088","volume":"19","author":"EW Harhaj","year":"1999","unstructured":"Harhaj EW, Sun SC. Regulation of RelA subcellular localization by a putative nuclear export signal and p50. Mol Cell Biol. 1999;19:7088\u201395.","journal-title":"Mol Cell Biol"},{"key":"8846_CR36","doi-asserted-by":"publisher","first-page":"a003004","DOI":"10.1101\/cshperspect.a003004","volume":"2","author":"M Thome","year":"2010","unstructured":"Thome M, Charton JE, Pelzer C, Hailfinger S. Antigen receptor signaling to NF-kappaB via CARMA1, BCL10, and MALT1. Cold Spring Harb Perspect Biol. 2010;2:a003004.","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"8846_CR37","doi-asserted-by":"publisher","first-page":"4634","DOI":"10.1038\/sj.emboj.7601897","volume":"26","author":"A Oeckinghaus","year":"2007","unstructured":"Oeckinghaus A, Wegener E, Welteke V, Ferch U, Arslan SC, Ruland J, et al. Malt1 ubiquitination triggers NF-kappaB signaling upon T-cell activation. EMBO J. 2007;26:4634\u201345.","journal-title":"EMBO J"},{"key":"8846_CR38","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1146\/annurev.immunol.18.1.621","volume":"18","author":"M Karin","year":"2000","unstructured":"Karin M, Ben-Neriah Y. Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity. Annu Rev Immunol. 2000;18:621\u201363.","journal-title":"Annu Rev Immunol"},{"key":"8846_CR39","doi-asserted-by":"publisher","first-page":"a000158","DOI":"10.1101\/cshperspect.a000158","volume":"2","author":"A Israel","year":"2010","unstructured":"Israel A. The IKK complex, a central regulator of NF-kappaB activation. Cold Spring Harb Perspect Biol. 2010;2:a000158.","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"8846_CR40","doi-asserted-by":"publisher","first-page":"jcs258601.","DOI":"10.1242\/jcs.258601","volume":"134","author":"S Priya","year":"2021","unstructured":"Priya S, Kaur E, Kulshrestha S, Pandit A, Gross I, Kumar N, et al. CDX2 inducible microRNAs sustain colon cancer by targeting multiple DNA damage response pathway factors. J Cell Sci. 2021;134:jcs258601.","journal-title":"J Cell Sci"},{"key":"8846_CR41","doi-asserted-by":"publisher","first-page":"11528","DOI":"10.1093\/nar\/gku856","volume":"42","author":"JB Budhathoki","year":"2014","unstructured":"Budhathoki JB, Ray S, Urban V, Janscak P, Yodh JG, Balci H. RecQ-core of BLM unfolds telomeric G-quadruplex in the absence of ATP. Nucleic Acids Res. 2014;42:11528\u201345.","journal-title":"Nucleic Acids Res"},{"key":"8846_CR42","doi-asserted-by":"publisher","first-page":"38.","DOI":"10.3390\/biomedicines6020038","volume":"6","author":"P Grondona","year":"2018","unstructured":"Grondona P, Bucher P, Schulze-Osthoff K, Hailfinger S, Schmitt A. NF-kappaB activation in lymphoid malignancies: genetics, signaling, and targeted therapy. Biomedicines. 2018;6:38.","journal-title":"Biomedicines"},{"key":"8846_CR43","doi-asserted-by":"publisher","first-page":"3557.","DOI":"10.3390\/cancers14143557","volume":"14","author":"B Di Francesco","year":"2022","unstructured":"Di Francesco B, Verzella D, Capece D, Vecchiotti D, Di Vito Nolfi M, Flati I, et al. NF-kappaB: a druggable target in acute myeloid leukemia. Cancers. 2022;14:3557.","journal-title":"Cancers"},{"key":"8846_CR44","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/s41392-024-01757-9","volume":"9","author":"Q Guo","year":"2024","unstructured":"Guo Q, Jin Y, Chen X, Ye X, Shen X, Lin M, et al. NF-kappaB in biology and targeted therapy: new insights and translational implications. Signal Transduct Target Ther. 2024;9:53.","journal-title":"Signal Transduct Target Ther"},{"key":"8846_CR45","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1038\/sj.cdd.4401874","volume":"13","author":"T Braun","year":"2006","unstructured":"Braun T, Carvalho G, Fabre C, Grosjean J, Fenaux P, Kroemer G. Targeting NF-kappaB in hematologic malignancies. Cell Death Differ. 2006;13:748\u201358.","journal-title":"Cell Death Differ"},{"key":"8846_CR46","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.18632\/oncotarget.819","volume":"3","author":"L Fontan","year":"2012","unstructured":"Fontan L, Melnick A. Targeting lymphomas through MALT1 inhibition. Oncotarget. 2012;3:1493\u20134.","journal-title":"Oncotarget"},{"key":"8846_CR47","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1080\/10428194.2021.1999444","volume":"63","author":"MR Seshadri","year":"2022","unstructured":"Seshadri MR, Melnick AM. Targeting MALT1 for the treatment of diffuse large B-cell lymphoma. Leuk Lymphoma. 2022;63:789\u201398.","journal-title":"Leuk Lymphoma"},{"key":"8846_CR48","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1159\/000452082","volume":"8","author":"C Cunniff","year":"2017","unstructured":"Cunniff C, Bassetti JA, Ellis NA. Bloom\u2019s syndrome: clinical spectrum, molecular pathogenesis, and cancer predisposition. Mol Syndromol. 2017;8:4\u201323.","journal-title":"Mol Syndromol"},{"key":"8846_CR49","doi-asserted-by":"publisher","first-page":"3382","DOI":"10.1101\/gad.12.21.3382","volume":"12","author":"N Chester","year":"1998","unstructured":"Chester N, Kuo F, Kozak C, O\u2019Hara CD, Leder P. Stage-specific apoptosis, developmental delay, and embryonic lethality in mice homozygous for a targeted disruption in the murine Bloom\u2019s syndrome gene. Genes Dev. 1998;12:3382\u201393.","journal-title":"Genes Dev"},{"key":"8846_CR50","doi-asserted-by":"publisher","first-page":"953","DOI":"10.4049\/jimmunol.178.2.953","volume":"178","author":"PJ Jost","year":"2007","unstructured":"Jost PJ, Weiss S, Ferch U, Gross O, Mak TW, Peschel C, et al. Bcl10\/Malt1 signaling is essential for TCR-induced NF-kappaB activation in thymocytes but dispensable for positive or negative selection. J Immunol. 2007;178:953\u201360.","journal-title":"J Immunol"},{"key":"8846_CR51","doi-asserted-by":"publisher","first-page":"2671","DOI":"10.1084\/jem.20091802","volume":"206","author":"MW Tusche","year":"2009","unstructured":"Tusche MW, Ward LA, Vu F, McCarthy D, Quintela-Fandino M, Ruland J, et al. Differential requirement of MALT1 for BAFF-induced outcomes in B cell subsets. J Exp Med. 2009;206:2671\u201383.","journal-title":"J Exp Med"},{"key":"8846_CR52","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/cr.2010.168","volume":"21","author":"J Staal","year":"2011","unstructured":"Staal J, Bekaert T, Beyaert R. Regulation of NF-kappaB signaling by caspases and MALT1 paracaspase. Cell Res. 2011;21:40\u201354.","journal-title":"Cell Res"},{"key":"8846_CR53","doi-asserted-by":"publisher","first-page":"2967","DOI":"10.1016\/j.celrep.2016.08.069","volume":"16","author":"C Lescale","year":"2016","unstructured":"Lescale C, Lenden Hasse H, Blackford AN, Balmus G, Bianchi JJ, Yu W, et al. Specific roles of XRCC4 paralogs PAXX and XLF during V(D)J recombination. Cell Rep. 2016;16:2967\u201379.","journal-title":"Cell Rep"},{"key":"8846_CR54","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1084\/jem.20070255","volume":"204","author":"P Soulas-Sprauel","year":"2007","unstructured":"Soulas-Sprauel P, Le Guyader G, Rivera-Munoz P, Abramowski V, Olivier-Martin C, Goujet-Zalc C, et al. Role for DNA repair factor XRCC4 in immunoglobulin class switch recombination. J Exp Med. 2007;204:1717\u201327.","journal-title":"J Exp Med"},{"key":"8846_CR55","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.2147\/OTT.S161109","volume":"11","author":"L Xia","year":"2018","unstructured":"Xia L, Tan S, Zhou Y, Lin J, Wang H, Oyang L, et al. Role of the NFkappaB-signaling pathway in cancer. Onco Targets Ther. 2018;11:2063\u201373.","journal-title":"Onco Targets Ther"},{"key":"8846_CR56","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1158\/2326-6066.CIR-14-0112","volume":"2","author":"Y Xia","year":"2014","unstructured":"Xia Y, Shen S, Verma IM. NF-kappaB, an active player in human cancers. Cancer Immunol Res. 2014;2:823\u201330.","journal-title":"Cancer Immunol Res"},{"key":"8846_CR57","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1111\/cei.13662","volume":"206","author":"M Sonoda","year":"2021","unstructured":"Sonoda M, Ishimura M, Eguchi K, Yada Y, Lenhartova N, Shiraishi A, et al. Progressive B cell depletion in human MALT1 deficiency. Clin Exp Immunol. 2021;206:237\u201347.","journal-title":"Clin Exp Immunol"},{"key":"8846_CR58","doi-asserted-by":"publisher","first-page":"6623","DOI":"10.1158\/1078-0432.CCR-11-0467","volume":"17","author":"LM McAllister-Lucas","year":"2011","unstructured":"McAllister-Lucas LM, Baens M, Lucas PC. MALT1 protease: a new therapeutic target in B lymphoma and beyond? Clin Cancer Res. 2011;17:6623\u201331.","journal-title":"Clin Cancer Res"},{"key":"8846_CR59","first-page":"1348","volume":"109","author":"FM Safa","year":"2024","unstructured":"Safa FM, Rasmussen T, Fontan L, Xia M, Melnick A, Wiestner A, et al. Profiling the activity of the para-caspase MALT1 in B-cell acute lymphoblastic leukemia for potential targeted therapeutic application. Haematologica. 2024;109:1348\u201358.","journal-title":"Haematologica"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08846-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08846-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08846-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T13:02:45Z","timestamp":1783947765000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08846-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,20]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8846"],"URL":"https:\/\/doi.org\/10.1038\/s41419-026-08846-3","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,20]]},"assertion":[{"value":"25 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"636"}}